Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00357695 · ClinicalTrials.gov registry record

Role of the Brain in Processing Visually Presented Objects

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
45
Enrollment target

NCT00357695: Completed study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

NCT00357695 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00357695 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

This study will examine the parts of the brain that use visual information to perform movements. Patients with certain brain lesions tend to have difficulty in processing visually presented objects. This study will look at the brain mechanisms underlying the visuo-motor integration. Healthy normal volunteers between 20 and 60 years of age are eligible for this study. People who have had a severe head injury with loss of consciousness or any other mental or neurological disorder diagnosed by a doctor may not participate. Candidates will be screened with a medical history, a physical examination focusing on finger movements, and a questionnaire. Participants' brain activity will be recorded using two techniques - magnetoencephalography(MEG) and magnetic resonance imaging (MRI) - while they watch pictures of various objects flashed on a screen. MEG is a procedure to record magnetic field changes produced by brain activity. During the recording, the subject sits comfortably in an armchair in a dimly lit room and watches pictures presented on a screen. About 50 pictures are shown per session. There are about five sessions, separated by 3-minute breaks. Functional MRI involves taking pictures of the brain using MRI while the subject performs a task. MRI uses a strong magnetic field and radio waves to obtain images of body organs and tissues. The MRI scanner is a metal cylinder surrounded by a magnetic field. The subject lies still on a table that can slide in and out of the scanner. During the scan, he or she looks at pictures in six test blocks of 1 minute each, with 30-second breaks between blocks.

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2003-11-18
Est. Completion 2008-10-28

What the finished NCT00357695 record still lists

NCT00357695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00357695 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00357695 about?

NCT00357695 is a clinical study titled "Role of the Brain in Processing Visually Presented Objects". This study will examine the parts of the brain that use visual information to perform movements. Patients with certain brain lesions tend to have difficulty in processing visually presented objects. This study will look at the brain mechanisms underlying the visuo-motor integration. Healthy normal ...

What is the current status of trial NCT00357695?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2003-11-18. Estimated completion is 2008-10-28.

Who is sponsoring clinical trial NCT00357695?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00357695, the US trial registry maintained by the National Library of Medicine. NCT00357695 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.